Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-705

Simples.. FOMO.
Be it retail or others. We've shot up to $1.20 from 30c in the last 8 weeks on news that the fda will accept our application if we resubmit, this alone has drawn in investors and speculators to the party.
Last time we submitted $1.40ish was the peak before the insiders and "master traders" bailed leaving us with the TH and the bag.
So IMO $1.30 isn't that extraordinary considering we are about to resubmit, however this time round we were invited, we have ticked off all the boxes in another crl, there wouldn't be a resubmission if we weren't confident of approval IMO. FDA has softened allegedly, the possibility for a result in 2 mths after submission is exciting and msb directors are doing pushups and flexing wherever they go.
BULLISH!
Obviously something is different now.
The company has dropped the adult trial until the paediatric results are in. Something has changed.
Sharts have been dropping, jumping ship, they can see the writing on the wall.
GG using the force..
"buy more shares we must" (in yodas voice)

1+1+1= retirement.

I wish I bought more.